24 results
8-K
EX-99.1
CFRXQ
CONTRAFECT Corp
14 May 21
ContraFect Reports First Quarter 2021 Financial Results and Provides Business Update
4:55pm
the appointment of Jane F. Barlow, MD, MPH, MBA to the Company’s board of directors. Dr. Barlow is an expert in drug launch readiness and pricing
8-K
EX-10.1
2bp5 zn85
12 Mar 21
ContraFect Announces BARDA Contract Award for Up to $86.8 Million and Provides Business Outlook
8:30am
424B5
d5xv9lj6tgp4
26 May 20
Prospectus supplement for primary offering
4:39pm
424B5
g9zd1j
21 May 20
Prospectus supplement for primary offering
5:23pm
8-K
EX-1.1
jkup6vsal4pbq
19 Dec 19
Other Events
4:17pm
8-K
EX-1.1
75zw oitnouv0j8
12 Dec 19
Entry into a Material Definitive Agreement
5:03pm
10-K
0lvssh qub6wz
26 Mar 15
Annual report
12:00am
8-K
jqn49p5wqg lzc
21 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-1.1
ii2b9 heocotbpdp7ek
1 Aug 14
Contrafect Announces Pricing of Its
12:00am
424B1
u2kv9 5wx
29 Jul 14
Prospectus with pricing info
12:00am